Literature DB >> 19752730

Tubulointerstitial nephritis and uveitis syndrome.

Friederike Mackensen1, Heiko Billing.   

Abstract

PURPOSE OF REVIEW: Tubulointerstitial nephritis and uveitis syndrome (TINU) is a specific form of intraocular inflammation (uveitis) combined with kidney disease that was first described in two patients by Dobrin et al. in 1975. Since then, approximately 200 more cases have been published. The cause of the disease is still unknown. A hypersensitivity reaction is suspected, especially an infection or very rarely a medication reaction is thought to trigger the disease. It is considered to be a rare disease and thus unfortunately is still unfamiliar to most ophthalmologists. Therefore, it is frequently overlooked in the differential diagnosis. In this review we want to show advances in diagnostics and treatment as well as progress in deciphering the pathogenesis. RECENT
FINDINGS: Beta-2 microglobulin (Ub2MG) analysis in urine and human leukocyte antigen (HLA) typing is helpful to diagnose TINU cases. A high association of HLA-DRB1*01 has been shown with TINU. A first single case report suggests a common antibody production against ocular and renal proteins.
SUMMARY: TINU is a common cause of uveitis among patients who present with bilateral, anterior uveitis of sudden onset. It is more frequent in children and apparently in boys. Although the activity of the eye disease can persist for many months, it is usually controlled with little treatment and the outcome is very good.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19752730     DOI: 10.1097/ICU.0b013e3283318f9a

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  16 in total

Review 1.  Tubulointerstitial nephritis and uveitis.

Authors:  Kaivon Pakzad-Vaezi; Kathryn L Pepple
Journal:  Curr Opin Ophthalmol       Date:  2017-11       Impact factor: 3.761

Review 2.  The blind kidney: disorders affecting kidneys and eyes.

Authors:  Isabelle Russell-Eggitt; Detlef Bockenhauer
Journal:  Pediatr Nephrol       Date:  2013-01-24       Impact factor: 3.714

Review 3.  Gender disparities in ocular inflammatory disorders.

Authors:  Hatice Nida Sen; Janet Davis; Didar Ucar; Austin Fox; Chi Chao Chan; Debra A Goldstein
Journal:  Curr Eye Res       Date:  2014-07-02       Impact factor: 2.424

4.  Granulomatosis with polyangiitis: seeing the diagnosis.

Authors:  Max J Blumberg; Cynthia I Tung; Lindsay A May; Sangita P Patel
Journal:  BMJ Case Rep       Date:  2017-05-09

Review 5.  Cutting-edge issues in autoimmune uveitis.

Authors:  Roger A Levy; Francisco Assis de Andrade; Ivan Foeldvari
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

6.  Tubulointerstitial nephritis and uveitis (TINU) syndrome and recent Streptococcus infection in a 9-year-old girl.

Authors:  Robert Br Moreton; Brian W Fleck; Joyce Davidson; David Hughes
Journal:  BMJ Case Rep       Date:  2020-02-17

7.  Biopsy-proven paediatric tubulointerstitial nephritis.

Authors:  Marianella Howell; Neil J Sebire; Stephen D Marks; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2016-05-02       Impact factor: 3.714

8.  Prednisone in the treatment of tubulointerstitial nephritis in children.

Authors:  Timo Jahnukainen; Ville Saarela; Pekka Arikoski; Elisa Ylinen; Kai Rönnholm; Marja Ala-Houhala; Matti Nuutinen
Journal:  Pediatr Nephrol       Date:  2013-04-19       Impact factor: 3.714

9.  Pediatric uveitis.

Authors:  Ilknur Tugal-Tutkun
Journal:  J Ophthalmic Vis Res       Date:  2011-10

10.  Aetiology, course and treatment of acute tubulointerstitial nephritis in paediatric patients: a cross-sectional web-based survey.

Authors:  Sarah Wente-Schulz; Marina Aksenova; Atif Awan; Cahyani Gita Ambarsari; Francesca Becherucci; Francesco Emma; Marc Fila; Telma Francisco; Ibrahim Gokce; Bora Gülhan; Matthias Hansen; Timo Jahnukainen; Mahmoud Kallash; Konstantinos Kamperis; Sherene Mason; Antonio Mastrangelo; Francesca Mencarelli; Bogna Niwinska-Faryna; Michael Riordan; Rina R Rus; Seha Saygili; Erkin Serdaroglu; Sevgin Taner; Rezan Topaloglu; Enrico Vidal; Robert Woroniecki; Sibel Yel; Jakub Zieg; Lars Pape
Journal:  BMJ Open       Date:  2021-05-28       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.